$77.9 Million is the total value of DSC Advisors, L.P.'s 33 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 50.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CVS | Buy | CVS HEALTH CORP | $13,769,342 | +30.0% | 197,212 | +28.7% | 17.68% | +11.3% |
R1 RCM INC | $12,673,870 | -18.3% | 841,000 | 0.0% | 16.27% | -30.1% | ||
BMRN | BIOMARIN PHARMACEUTICAL INC | $8,848,000 | +2.1% | 100,000 | 0.0% | 11.36% | -12.6% | |
ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $7,265,347 | -20.2% | 64,742 | +3.5% | 9.33% | -31.7% |
ABT | Buy | ABBOTT LABS | $6,749,477 | +49.5% | 69,690 | +68.3% | 8.66% | +28.0% |
GOOG | ALPHABET INCcap stk cl c | $6,065,100 | +9.0% | 46,000 | 0.0% | 7.79% | -6.7% | |
GOOG | New | ALPHABET INCcall | $6,065,100 | – | 46,000 | +100.0% | 7.79% | – |
ABT | New | ABBOTT LABScall | $3,486,600 | – | 36,000 | +100.0% | 4.48% | – |
EHTH | Buy | EHEALTH INC | $3,034,000 | -0.7% | 410,000 | +7.9% | 3.90% | -15.0% |
TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $2,983,500 | +27.8% | 292,500 | -5.6% | 3.83% | +9.4% |
Buy | ENHABIT INC | $815,625 | +609.2% | 72,500 | +625.0% | 1.05% | +508.7% | |
UNG | New | UNITED STS NAT GAS FD LPcall | $683,000 | – | 100,000 | +100.0% | 0.88% | – |
New | ENHABIT INCcall | $596,250 | – | 53,000 | +100.0% | 0.76% | – | |
ODP | New | THE ODP CORP | $461,500 | – | 10,000 | +100.0% | 0.59% | – |
VYNE THERAPEUTICS INC | $460,000 | -1.5% | 115,000 | 0.0% | 0.59% | -15.6% | ||
MSFT | Buy | MICROSOFT CORP | $372,269 | +1.9% | 1,179 | +9.9% | 0.48% | -12.8% |
GOOGL | Sell | ALPHABET INCcap stk cl a | $371,381 | +8.3% | 2,838 | -0.9% | 0.48% | -7.2% |
FB | Buy | META PLATFORMS INCcl a | $360,252 | +5.3% | 1,200 | +0.7% | 0.46% | -9.9% |
Buy | VIVID SEATS INC | $321,000 | +305.3% | 50,000 | +400.0% | 0.41% | +246.2% | |
V | Sell | VISA INC | $294,873 | -3.7% | 1,282 | -0.6% | 0.38% | -17.4% |
MA | Sell | MASTERCARD INCORPORATEDcl a | $293,369 | -1.7% | 741 | -2.4% | 0.38% | -15.8% |
ADBE | Sell | ADOBE INC | $261,579 | +0.2% | 513 | -3.9% | 0.34% | -14.3% |
CRM | Buy | SALESFORCE INC | $252,056 | +0.8% | 1,243 | +5.0% | 0.32% | -13.6% |
ACN | Buy | ACCENTURE PLC IRELAND | $252,752 | +0.7% | 823 | +1.2% | 0.32% | -13.8% |
BRKB | Buy | BERKSHIRE HATHAWAY INC DELcl b new | $233,650 | +9.1% | 667 | +6.2% | 0.30% | -6.5% |
AAPL | Buy | APPLE INC | $208,363 | -9.7% | 1,217 | +2.3% | 0.27% | -22.8% |
ORCL | Buy | ORACLE CORP | $205,908 | -10.0% | 1,944 | +1.2% | 0.26% | -23.0% |
ADT | New | ADT INC DEL | $180,000 | – | 30,000 | +100.0% | 0.23% | – |
JETS | New | ETF SER SOLUTIONSus glb jets | $170,300 | – | 10,000 | +100.0% | 0.22% | – |
GENI | New | GENIUS SPORTS LIMITEDshares cl a | $159,900 | – | 30,000 | +100.0% | 0.20% | – |
Exit | COMSOVEREIGN HLDG CORP | $0 | – | -22,500 | -100.0% | -0.06% | – | |
HBI | Exit | HANESBRANDS INCcall | $0 | – | -50,000 | -100.0% | -0.34% | – |
NFLX | Exit | NETFLIX INC | $0 | – | -519 | -100.0% | -0.34% | – |
KMPH | Exit | ZEVRA THERAPEUTICS INC | $0 | – | -49,100 | -100.0% | -0.38% | – |
KMPH | Exit | ZEVRA THERAPEUTICS INCcall | $0 | – | -131,700 | -100.0% | -1.01% | – |
BMRN | Exit | BIOMARIN PHARMACEUTICAL INCput | $0 | – | -25,000 | -100.0% | -3.25% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CVS HEALTH CORP | 39 | Q3 2023 | 21.2% |
MICROSOFT CORP | 38 | Q3 2023 | 2.9% |
APPLE INC | 37 | Q3 2023 | 2.7% |
META PLATFORMS INC | 37 | Q3 2023 | 1.6% |
UNITEDHEALTH GROUP INC | 37 | Q3 2022 | 1.5% |
ORACLE CORP | 35 | Q3 2023 | 0.6% |
INTERNATIONAL BUSINESS MACHS | 33 | Q3 2022 | 0.6% |
ALPHABET INC | 32 | Q3 2023 | 16.0% |
ALPHABET INC | 32 | Q3 2023 | 2.6% |
SALESFORCE INC | 30 | Q3 2023 | 0.9% |
View DSC Advisors, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
BioScrip, Inc. | March 12, 2015 | 1,842,241 | 2.7% |
TARRAGON CORPSold out | February 25, 2009 | 0 | 0.0% |
OGLEBAY NORTON CO /NEW/Sold out | September 29, 2006 | 0 | 0.0% |
JORGENSEN EARLE M CO /DE/ | August 08, 2005 | 2,444,200 | 5.0% |
AFFIRMATIVE INSURANCE HOLDINGS INC | June 15, 2005 | 1,159,699 | 7.8% |
VESTA INSURANCE GROUP INCSold out | December 30, 2004 | 0 | 0.0% |
HANGER ORTHOPEDIC GROUP INC | November 08, 2004 | 1,103,900 | 5.1% |
View DSC Advisors, L.P.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View DSC Advisors, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.